MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in
cash, cash...
-$247,000K
Stock-based compensation
$30,000K
Non-cash interest
expense on liabilities...
$21,000K
Accounts receivable
-$19,000K
Depreciation and
amortization
$8,000K
Other
-$1,000K
Proceeds from maturities
of marketable...
$88,000K
Net cash used in
operating activities
-$197,000K
Net cash (used in)
provided by investing...
-$49,000K
Effect of exchange rate
changes on cash
-$1,000K
Canceled cashflow
$79,000K
Canceled cashflow
$88,000K
Net loss
-$185,000K
Accounts payable,
accrued, and other...
-$57,000K
Purchase of marketable
securities
$131,000K
Non-cash royalty revenue
$20,000K
Prepaid expenses and
other assets
$9,000K
Inventory
$4,000K
Amortization of discount on
marketable securities, net
$1,000K
Payments for intangible
asset
$5,000K
Purchase of property,
plant, and equipment
$1,000K
Back
Back
Cash Flow
source: myfinsight.com
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)